Healthcare Innovations II, 1
Back to All Secondary TrustsPortfolio Holdings by Security (As of Deposit Date)
Ticker | Security Description | Deposit % |
---|---|---|
AGEN | Agenus, Inc. | 3.33 |
ALDX | Aldeyra Therapeutics, Inc. | 3.30 |
AMLX | Amylyx Pharmaceuticals, Inc. | 3.35 |
ARCT | Arcturus Therapeutics Holdings Inc. | 3.38 |
ARDX | Ardelyx, Inc. | 3.36 |
AXSM | Axsome Therapeutics, Inc. | 3.35 |
BTAI | BioXcel Therapeutics, Inc. | 3.34 |
CBAY | CymaBay Therapeutics, Inc. | 3.30 |
CRNX | Crinetics Pharmaceuticals, Inc. | 3.28 |
CRSP | CRISPR Therapeutics AG | 3.32 |
DAWN | Day One Biopharmaceuticals, Inc. | 3.37 |
HCM | HUTCHMED (China) Ltd. | 3.34 |
ICPT | Intercept Pharmaceuticals, Inc. | 3.31 |
IMGN | ImmunoGen, Inc. | 3.41 |
INBX | Inhibrx, Inc. | 3.30 |
INSM | Insmed Incorporated | 3.30 |
JAZZ | Jazz Pharmaceuticals plc | 3.36 |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 3.31 |
KRYS | Krystal Biotech, Inc. | 3.29 |
MIRM | Mirum Pharmaceuticals, Inc. (5) | 3.34 |
PTGX | Protagonist Therapeutics, Inc. | 3.41 |
RAPT | Rapt Therapeutics, Inc. | 3.36 |
RCKT | Rocket Pharmaceuticals, Inc. | 3.34 |
RNA | Avidity Biosciences, Inc. | 3.37 |
RYTM | Rhythm Pharmaceuticals, Inc. | 3.28 |
SAGE | Sage Therapeutics, Inc. | 3.29 |
TEVA | Teva Pharmaceutical Industries Ltd. | 3.32 |
VRDN | Viridian Therapeutics, Inc. | 3.32 |
VTRS | Viatris, Inc. | 3.32 |
ZLAB | Zai Lab Limited | 3.35 |
Health Care
Ticker | Security Description | Deposit % |
---|---|---|
AGEN | Agenus, Inc. | 3.33 |
ALDX | Aldeyra Therapeutics, Inc. | 3.30 |
AMLX | Amylyx Pharmaceuticals, Inc. | 3.35 |
ARCT | Arcturus Therapeutics Holdings Inc. | 3.38 |
ARDX | Ardelyx, Inc. | 3.36 |
RNA | Avidity Biosciences, Inc. | 3.37 |
AXSM | Axsome Therapeutics, Inc. | 3.35 |
BTAI | BioXcel Therapeutics, Inc. | 3.34 |
CRNX | Crinetics Pharmaceuticals, Inc. | 3.28 |
CRSP | CRISPR Therapeutics AG | 3.32 |
CBAY | CymaBay Therapeutics, Inc. | 3.30 |
DAWN | Day One Biopharmaceuticals, Inc. | 3.37 |
HCM | HUTCHMED (China) Ltd. | 3.34 |
IMGN | ImmunoGen, Inc. | 3.41 |
INBX | Inhibrx, Inc. | 3.30 |
INSM | Insmed Incorporated | 3.30 |
ICPT | Intercept Pharmaceuticals, Inc. | 3.31 |
JAZZ | Jazz Pharmaceuticals plc | 3.36 |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 3.31 |
KRYS | Krystal Biotech, Inc. | 3.29 |
MIRM | Mirum Pharmaceuticals, Inc. (5) | 3.34 |
PTGX | Protagonist Therapeutics, Inc. | 3.41 |
RAPT | Rapt Therapeutics, Inc. | 3.36 |
RYTM | Rhythm Pharmaceuticals, Inc. | 3.28 |
RCKT | Rocket Pharmaceuticals, Inc. | 3.34 |
SAGE | Sage Therapeutics, Inc. | 3.29 |
TEVA | Teva Pharmaceutical Industries Ltd. | 3.32 |
VTRS | Viatris, Inc. | 3.32 |
VRDN | Viridian Therapeutics, Inc. | 3.32 |
ZLAB | Zai Lab Limited | 3.35 |
Summary
Description
-
Trust Name Healthcare Innovations II, 1
-
Trust Symbol STHCAX
-
ML Symbol HCITII1
Deposit Data
-
Deposit Date 05/04/2023
-
Termination Date 20250501
-
Minimum Investment 100
-
Distribution Frequency Monthly (if any)
-
Initial Public Offer Price $10.00
-
Historical 12-Month Dist.* 0.0175
CUSIP
-
Cash Cusip 83207C712
-
Reinvest Cusip 83207C720
-
Fee Cash Cusip 83207C738
-
Fee Invest Cusip 83207C746
Documents
*The Historical 12-Month Distribution of Trust Holdings is as of 10/01/2024. If the Trust deposited after, or 90 days prior to, 10/01/2024, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.